Dr. Ken Bassett, co-manager of the Therapeutics Initiative in the Department of Anesthesiology, Pharmacology and Therapeutics at UBC, joins the show to discuss policy issues involving medications and rare diseases.

Dr. Ken Bassett, co-manager of the Therapeutics Initiative in the Department of Anesthesiology, Pharmacology and Therapeutics at UBC, joins the show to discuss policy issues involving medications and rare diseases.

Dr. Ken Bassett, co-manager of the Therapeutics Initiative in the Department of Anesthesiology, Pharmacology and Therapeutics at UBC, joins the show to discuss policy issues involving medications and rare diseases.&nbsp;

“Almost no comparison:” drug policy expert talks issues involving medications and rare diseases

If it happens on Vancouver Island &ndash; good or bad &ndash; we need to talk about it. Every hour in every show we deep dive into every nook and cranny of Victoria politics and learn the truth about how YOUR life will be affected. Adam Stirling explores and debates the latest news and current affairs every weekday from 11am to 3pm on CFAX 1070.

News

Politics

If it happens on Vancouver Island – good or bad – we need to talk about it. Every hour in every show we deep dive into every nook and cranny of Victoria politics and learn the truth about how YOUR life will be affected. Adam Stirling explores and debates the latest news and current affairs every weekday from 11am to 3pm on CFAX 1070.

If it happens on Vancouver Island – good or bad – we need to talk about it. Every hour in every show we deep dive into every nook and cranny of Victoria politics and learn the truth about how YOUR life will be affected. Adam Stirling explores and debates the latest news and current affairs every weekday from 11am to 3pm on CFAX 1070.

Share “Almost no comparison:” drug policy expert talks issues involving medications and rare diseases

Sign up to save your podcasts

“Almost no comparison:” drug policy expert talks issues involving medications and rare diseases

“Almost no comparison:” drug policy expert talks issues involving medications and rare diseases